(Q38737059)

English

Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2).

scientific article published on 28 May 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 September 2017

Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2). (English)

1 reference

Europe PubMed Central

6 September 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Yingyi Liu

1

1 reference

Europe PubMed Central

6 September 2017

Sujie Gao

2

1 reference

Europe PubMed Central

6 September 2017

Xuebo Chen

3

1 reference

Europe PubMed Central

6 September 2017

Meihan Liu

4

1 reference

Europe PubMed Central

6 September 2017

Cuiying Mao

5

1 reference

Europe PubMed Central

6 September 2017

Xuedong Fang

6

1 reference

Europe PubMed Central

6 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

28 May 2016

1 reference

Europe PubMed Central

6 September 2017

1 reference

Europe PubMed Central

6 September 2017

37

1 reference

Europe PubMed Central

6 September 2017

9

1 reference

Europe PubMed Central

6 September 2017

12231-12239

1 reference

Europe PubMed Central

6 September 2017

https://scigraph.springernature.com/pub.10.1007/s13277-016-5066-2

0 references

Colorectal carcinoma in the first decade of life: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Adjuvant therapy of colon cancer: current status and future directions.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

A systematic review of treatment guidelines for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Molecular aspects of resistance to biological and non-biological drugs and strategies to overcome resistance in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

A review of the evolution of systemic chemotherapy in the management of colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Overview of systemic therapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Paclitaxel formulations: challenges and novel delivery options.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Insights into the mechanism of microtubule stabilization by Taxol.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Mechanisms of Taxol resistance related to microtubules.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Diversifying microRNA sequence and function

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Regulation of microRNA biogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

MicroRNAs in cancer: biomarkers, functions and therapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

MicroRNA biogenesis pathways in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the Warburg effect in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5066-2

21 January 2018

miR-203 inhibits cell proliferation and migration of lung cancer cells by targeting PKCα

1 reference

https://pubmed.ncbi.nlm.nih.gov/27236538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/27236538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MicroRNA-203 induces apoptosis by upregulating Puma expression in colon and lung cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27236538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-016-5066-2

1 reference

Europe PubMed Central

6 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38737059&oldid=1630782638"